Reduction in Remnant Cholesterol in Obese Individuals After Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy

Overview

Journal Nutrients

Date 2025 Jan 11

PMID 39796622

Authors

Jan O Aaseth

Kjetil Retterstol

Helge Rootwelt

Per G Farup

Affiliations

Soon will be listed here.

Abstract

The effectiveness of bariatric surgery in reducing remnant cholesterol (RC) levels, particularly when obesity is accompanied by elevated glycated hemoglobin (HbA1c), is insufficiently investigated. In this study, we aimed to examine the impacts of two common bariatric procedures, Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), as regards their effects on RC and HbA1c levels. Adult morbidly obese subjects were included and assigned to receive either RYGB or SG. The levels of RC and HbA1c were determined 6 and 12 months after surgery and compared to preoperative levels to assess the efficacy of these surgical methods. In the statistical evaluation of covariations between RC and other biomarkers, previously determined C-reactive protein (CRP), triglycerides, apolipoprotein B, apolipoprotein A1, and low- and high-density lipoprotein cholesterol 6 and 12 months after surgery were included. A linear mixed regression model for repeated analyses was used. The RC levels were markedly reduced both after RYGB and SG but without significant differences between the RYGB and the SG surgery. Furthermore, the RC values were strongly associated with the levels of CRP and HbA1c. A significant lowering of RC values after bariatric surgery appeared paralleled by concomitant reductions in HbA1c values and CRP levels. Together, these effects lead to a lower risk of cardiovascular disease.

References

Chen X, Li L . Remnant Cholesterol, a Valuable Biomarker for Assessing Arteriosclerosis and Cardiovascular Risk: A Systematic Review. Cureus. 2023; 15(8):e44202. PMC: 10521762. DOI: 10.7759/cureus.44202. View

Vavlukis M, Vavlukis A . Adding ezetimibe to statin therapy: latest evidence and clinical implications. Drugs Context. 2018; 7:212534. PMC: 6044319. DOI: 10.7573/dic.212534. View

Ginsberg H, Packard C, Chapman M, Boren J, Aguilar-Salinas C, Averna M . Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021; 42(47):4791-4806. PMC: 8670783. DOI: 10.1093/eurheartj/ehab551. View

Langsted A, Madsen C, Nordestgaard B . Contribution of remnant cholesterol to cardiovascular risk. J Intern Med. 2020; 288(1):116-127. DOI: 10.1111/joim.13059. View

Bastien M, Poirier P, Lemieux I, Despres J . Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014; 56(4):369-81. DOI: 10.1016/j.pcad.2013.10.016. View

Hofso D, Fatima F, Borgeraas H, Birkeland K, Gulseth H, Hertel J . Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2019; 7(12):912-924. DOI: 10.1016/S2213-8587(19)30344-4. View

Castaner O, Pinto X, Subirana I, Amor A, Ros E, Hernaez A . Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease. J Am Coll Cardiol. 2020; 76(23):2712-2724. DOI: 10.1016/j.jacc.2020.10.008. View

Adams T, Mehta T, Davidson L, Hunt S . All-Cause and Cause-Specific Mortality Associated with Bariatric Surgery: A Review. Curr Atheroscler Rep. 2015; 17(12):74. PMC: 5055056. DOI: 10.1007/s11883-015-0551-4. View

Borgeraas H, Hofso D, Hertel J, Hjelmesaeth J . Comparison of the effect of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2020; 21(6):e13011. PMC: 7317556. DOI: 10.1111/obr.13011. View

10.

Doi T, Langsted A, Nordestgaard B . Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction. J Am Coll Cardiol. 2022; 79(24):2383-2397. PMC: 8972554. DOI: 10.1016/j.jacc.2022.03.384. View

11.

Huh J, Han K, Cho Y, Roh E, Kang J, Lee S . Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study. Cardiovasc Diabetol. 2022; 21(1):228. PMC: 9632127. DOI: 10.1186/s12933-022-01667-6. View

12.

Wang H, Guo Y, Zhang H, Wang X, Zheng X . The U-shaped association between remnant cholesterol and risk of all-cause and cardiovascular deaths in diabetic adults: Findings from NHANES 1999-2018. Nutr Metab Cardiovasc Dis. 2024; 34(10):2282-2288. DOI: 10.1016/j.numecd.2024.05.011. View

13.

Zhao S, Horkko S, Savolainen M, Koivukangas V, Makinen V, Ala-Korpela M . Short-Term Metabolic Changes and Their Physiological Mediators in the Roux-en-Y Gastric Bypass Bariatric Surgery. Obes Surg. 2024; 34(2):625-634. PMC: 10810963. DOI: 10.1007/s11695-023-07042-y. View

14.

Velazquez A, Apovian C . Updates on obesity pharmacotherapy. Ann N Y Acad Sci. 2018; 1411(1):106-119. DOI: 10.1111/nyas.13542. View

15.

Varbo A, Benn M, Tybjaerg-Hansen A, Nordestgaard B . Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013; 128(12):1298-309. DOI: 10.1161/CIRCULATIONAHA.113.003008. View

16.

Varbo A, Freiberg J, Nordestgaard B . Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study. Clin Chem. 2017; 64(1):219-230. DOI: 10.1373/clinchem.2017.279463. View

17.

Carlsson L, Sjoholm K, Jacobson P, Andersson-Assarsson J, Svensson P, Taube M . Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study. N Engl J Med. 2020; 383(16):1535-1543. PMC: 7580786. DOI: 10.1056/NEJMoa2002449. View

18.

Wang Z, Nakayama T . Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010; 2010:535918. PMC: 2929614. DOI: 10.1155/2010/535918. View

19.

Jansen A, Polder A, Muller M, Skjerve E, Aaseth J, Lyche J . Increased levels of persistent organic pollutants in serum one year after a great weight loss in humans: Are the levels exceeding health based guideline values?. Sci Total Environ. 2018; 622-623:1317-1326. DOI: 10.1016/j.scitotenv.2017.11.241. View

20.

Fried M, Yumuk V, Oppert J, Scopinaro N, Torres A, Weiner R . Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 2013; 24(1):42-55. DOI: 10.1007/s11695-013-1079-8. View